Answered

Get the information you need quickly and easily with IDNLearn.com. Explore a wide array of topics and find reliable answers from our experienced community members.

Which of the following is true regarding immune-related adverse events associated with the use of immune checkpoint inhibitor therapy?

A. These reactions are highly correlated with the second dose of checkpoint inhibitor therapy.
B. These reactions may have delayed onset and may be inflammatory or autoimmune in nature.
C. Corticosteroids should only be given for grade 3 toxicities.
D. These reactions are less likely to occur when checkpoint inhibitor therapy is combined with targeted therapy.

Sagot :

GinnyAnsweridn

Final answer:

Immune-related adverse events with immune checkpoint inhibitors can have delayed onset and may be inflammatory/autoimmune. Corticosteroids may be necessary for grade 3 toxicities, and the reactions are not less likely with combined therapy.


Explanation:

Regarding immune-related adverse events associated with the use of immune checkpoint inhibitor therapy:

  1. These reactions may have delayed onset and may be inflammatory or autoimmune in nature.
  2. Corticosteroids may need to be given for grade 3 or higher toxicities.
  3. These reactions are not less likely to occur when checkpoint inhibitor therapy is combined with targeted therapy.

Learn more about Immune-related adverse events with immune checkpoint inhibitors here:

https://brainly.com/question/28408407


We appreciate your contributions to this forum. Don't forget to check back for the latest answers. Keep asking, answering, and sharing useful information. Your search for answers ends at IDNLearn.com. Thank you for visiting, and we hope to assist you again soon.